Literature DB >> 10367286

A cloning vector for efficient generation of cholera toxin B gene fusions for epitope screening.

I Secundino1, J Paniagua-Solís, A Isibasi, J Sanchez.   

Abstract

Gene fusion proteins with epitopes attached to the amino end of cholera toxin B subunit (CTB) are useful to raise immunological responses. We describe a cloning vector, designated pCTBtet, carrying a tetracycline resistance gene (TetR) between the leader peptide and mature CTB. Removal of TetR to insert oligonucleotides encoding fusion epitopes allowed for screening of tetracycline-sensitive clones. Restoration of the correct CTB reading phase was subsequently used to choose gene fusion candidate colonies. The use of pCTBtet permitted the rapid construction of 8 fusion proteins carrying 9-24 aa from Salmonella typhi OmpC and 6 hybrids with 7-31 aa from Escherichia coli colonization factor CFAI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367286     DOI: 10.1007/BF02789180

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  14 in total

Review 1.  Cholera as a model for research on mucosal immunity and development of oral vaccines.

Authors:  J Holmgren; C Czerkinsky
Journal:  Curr Opin Immunol       Date:  1992-08       Impact factor: 7.486

2.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination.

Authors:  J Sanchez; S Johansson; B Löwenadler; A M Svennerholm; J Holmgren
Journal:  Res Microbiol       Date:  1990 Sep-Oct       Impact factor: 3.992

4.  Immunological characterization of a rotavirus-neutralizing epitope fused to the cholera toxin B subunit.

Authors:  R A González; J Sánchez; J Holmgren; S López; C F Arias
Journal:  Gene       Date:  1993-11-15       Impact factor: 3.688

5.  Expression in Escherichia coli of two mutated genes encoding the cholera toxin B subunit.

Authors:  C L'hoir; A Renard; J A Martial
Journal:  Gene       Date:  1990-04-30       Impact factor: 3.688

6.  Construction of CTB fusion proteins for screening of monoclonal antibodies against Salmonella typhi OmpC peptide loops.

Authors:  J Paniagua-Solís; J Sánchez; V Ortiz-Navarrete; C R González; A Isibasi
Journal:  FEMS Microbiol Lett       Date:  1996-07-15       Impact factor: 2.742

7.  Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.

Authors:  E T Ryan; J R Butterton; T Zhang; M A Baker; S L Stanley; S B Calderwood
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

8.  Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit.

Authors:  J Sanchez; A M Svennerholm; J Holmgren
Journal:  FEBS Lett       Date:  1988-12-05       Impact factor: 4.124

9.  Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.

Authors:  M Bckström; J Holmgren; F Schödel; M Lebens
Journal:  Gene       Date:  1995-11-20       Impact factor: 3.688

10.  Immunologic characteristics of a Streptococcus mutans glucosyltransferase B sucrose-binding site peptide-cholera toxin B-subunit chimeric protein.

Authors:  P Laloi; C L Munro; K R Jones; F L Macrina
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

View more
  1 in total

1.  Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response.

Authors:  Ismael Secundino; Constantino López-Macías; Luisa Cervantes-Barragán; Cristina Gil-Cruz; Nora Ríos-Sarabia; Rodolfo Pastelin-Palacios; Miguel Angel Villasis-Keever; Ingeborg Becker; José Luis Puente; Edmundo Calva; Armando Isibasi
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.